- Home
- Labeler Index
- Takeda Pharmaceuticals America, Inc.
- 42227-083
- NDC Crossover: 42227-083 Cinryze
NDC Crossover 42227-083 Cinryze
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 42227-083 – Cinryze, a plasma derivative. This list includes other cross-matching products that share:
- The same product name: Cinryze
- OR Generic name: Human C1-esterase Inhibitor
- AND the same Administration Route:
- OR Dosage Form: kit
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 42227-081 | Cinryze | Human C1-esterase Inhibitor | Injection, Powder, Lyophilized, For Solution | Intravenous | Takeda Pharmaceuticals America, Inc. | Plasma Derivative |
| 63833-825 | Berinert | Human C1-esterase Inhibitor | Kit | Csl Behring Gmbh | Plasma Derivative |
